CBS 2019
CBSMD教育中心
中 文

Percutaneous LAA Occlusion

Abstract

Recommended Article

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

JOURNAL: Article Link

CBS2025丨日程框架一览,大会亮点抢鲜看,更多精彩敬请期待~

qiaomingyue Keywords: 2025年11月28日-30日,“第十七届左主干暨冠状动脉分叉病变会议(CBS 2025)” 将在六朝古都南京启幕。CBS 2025将以“临床精进、科研突破、能力建设”三大核心维度为基石,汇聚国内外心血管领域顶尖智慧,聚焦复杂冠脉介入、肺动脉高压、心力衰竭、高血压、心律失常、超声心动图、临床并发症和疑难病例以及基础研究、临床研究培训等前沿领域,打造一场融合理论与实践、贯通创新与经验的高水平学术交流。

网站资料更新中...